1. Cost of Medicare for All: Review of the Estimates

   • John A. Nyman

   Current Opinion 25 January 2021 Pages: 453 - 461

2. Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines

   • Chris Painter
   • Wanrudee Isaranuwatchai
   • Yot Teerawattananon

   Practical Application 08 July 2021 Pages: 463 - 472

   

3. Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations

   • M. Cochrane
   • E. Mitchell
   • D. Trépel

   Systematic Review 01 March 2021 Pages: 473 - 486

   

4. Economic Analyses of Pathogen-Reduction Technologies in Blood Transfusion: A Systematic Literature Review

   • Patrick R. LaFontaine
   • Jing Yuan
   • Laura T. Pizzi

   Systematic Review 08 February 2021 Pages: 487 - 499

   

5. Costs of Illness of Spinal Muscular Atrophy: A Systematic Review

   • Erik Landfeldt
   • Astrid Pechmann
   • Thomas Sejersen

   Systematic Review Open access 12 February 2021 Pages: 501 - 520

   

6. Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

   • James Buchanan
   • Laurence S. J. Roope
   • Sarah Wordsworth

   Original Research Article Open access 08 March 2021 Pages: 521 - 535

   

7. Opioid Prescribing in Canada following the Legalization of Cannabis: A Clinical and Economic Time-Series Analysis

   • George Dranitsaris
   • Carlo DeAngelis
   • Bernd Pohlmann-Eden

   Original Research Article 25 January 2021 Pages: 537 - 544

   

8. Cost-Effectiveness and Value of Information of Cabozantinib Treatment for Patients with Advanced Renal Cell Carcinoma After Failure of Prior Therapy in South Korea

   • Siin Kim
   • Sola Han
   • Hae Sun Suh

   Original Research Article 02 March 2021 Pages: 545 - 555

   

9. The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil

   • Wânia Cristina da Silva
   • Brian Godman
   • Eli Iola Gurgel Andrade

   Original Research Article 28 January 2021 Pages: 557 - 577

   

10. The Danish EQ-5D-5L Value Set: A Hybrid Model Using cTTO and DCE Data

    • Cathrine Elgaard Jensen
    • Sabrina Storgaard Sørensen
    • Lars Holger Ehlers

    Original Research Article Open access 02 February 2021 Pages: 579 - 591

    

11. Cost-Effectiveness Analysis of Parenteral Methotrexate for the Treatment of Crohn’s Disease

    • Tomas Mlcoch
    • Barbora Decker
    • Tomas Dolezal

    Original Research Article 11 January 2021 Pages: 593 - 604

    

12. Does Biosimilar Bevacizumab Offer Affordable Treatment Options for Cancer Patients in the USA? A Budget Impact Analysis from US Commercial and Medicare Payer Perspectives

    • Jingyan Yang
    • Rongzhe Liu
    • Ahmed Shelbaya

    Original Research Article Open access 28 January 2021 Pages: 605 - 618

    

13. Comment on: “Willingness to Pay for a COVID-19 Vaccine”

    • Philipp Sprengholz
    • Cornelia Betsch

    Letter to the Editor Open access 11 May 2021 Pages: 619 - 621

    

14. Authors’ Reply to Sprengholz and Betsch: “Willingness to Pay for a COVID-19 Vaccine”

    • Leidy Y. García
    • Arcadio A. Cerda

    Letter to the Editor 11 May 2021 Pages: 623 - 624